BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11877365)

  • 41. Effect of rilmenidine on baroreflex control of renal sympathetic nerve activity.
    Sannajust F; Head GA
    J Hypertens Suppl; 1993 Dec; 11(5):S328-9. PubMed ID: 7908964
    [No Abstract]   [Full Text] [Related]  

  • 42. New concepts on the central regulation of blood pressure. Alpha 2-adrenoceptors and "imidazoline receptors".
    Bousquet P; Feldman J; Tibirica E; Bricca G; Molines A; Dontenwill M; Belcourt A
    Am J Med; 1989 Sep; 87(3C):10S-13S. PubMed ID: 2571290
    [TBL] [Abstract][Full Text] [Related]  

  • 43. alpha(2C)-Adrenergic receptors mediate spinal analgesia and adrenergic-opioid synergy.
    Fairbanks CA; Stone LS; Kitto KF; Nguyen HO; Posthumus IJ; Wilcox GL
    J Pharmacol Exp Ther; 2002 Jan; 300(1):282-90. PubMed ID: 11752127
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Non-adrenergic exploratory behavior induced by moxonidine at mildly hypotensive doses.
    Zhu H; Paul IA; Stec DE; Peeler DF; Piletz JE
    Brain Res; 2003 Feb; 964(1):9-20. PubMed ID: 12573508
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adrenergic and nonadrenergic effects of imidazoline and related antihypertensive drugs in the brain and periphery.
    Hamilton CA
    Am J Hypertens; 1992 Apr; 5(4 Pt 2):58S-63S. PubMed ID: 1596396
    [TBL] [Abstract][Full Text] [Related]  

  • 46. I(1) imidazoline receptors involved in cardiovascular regulation: where are we and where are we going?
    Bousquet P; Greney H; Bruban V; Schann S; Ehrhardt JD; Monassier L; Feldman J
    Ann N Y Acad Sci; 2003 Dec; 1009():228-33. PubMed ID: 15028592
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Moxonidine displays a presynaptic alpha-2-adrenoceptor-dependent synergistic sympathoinhibitory action at imidazoline-1 receptors.
    Schäfer U; Burgdorf C; Engelhardt A; Raasch W; Kurz T; Richardt G
    Ann N Y Acad Sci; 2003 Dec; 1009():265-9. PubMed ID: 15028597
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Do centrally-acting antihypertensive drugs act at non-adrenergic as well as alpha-2 adrenoceptor sites?
    Hamilton CA; Yakubu MA; Howie CA; Reid JL
    Clin Exp Hypertens A; 1992; 14(5):815-35. PubMed ID: 1327589
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Involvement of central alpha1- and alpha2-adrenoceptors on cardiovascular responses to moxonidine.
    Moreira TS; Takakura AC; Menani JV; Colombari E
    Eur J Pharmacol; 2007 Jun; 563(1-3):164-71. PubMed ID: 17382316
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Recent advances in the pharmacology of rilmenidine.
    Montastruc JL; Macquin-Mavier I; Tran MA; Damase-Michel C; Koenig-Berard E; Valet P
    Am J Med; 1989 Sep; 87(3C):14S-17S. PubMed ID: 2571291
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Preventive effect of rilmenidine on the occurrence of neurogenic ventricular arrhythmias in rabbits.
    Roegel JC; Yannoulis N; De Jong W; Feldman J; Bousquet P
    J Hypertens Suppl; 1998 Aug; 16(3):S39-43. PubMed ID: 9747909
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Importance of imidazoline receptors in the cardiovascular responses to clonidine and rilmenidine in conscious rabbits.
    Head GA; Sannajust F
    Fundam Clin Pharmacol; 1992; 6 Suppl 1():31S-34S. PubMed ID: 1354632
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Moxonidine and rilmenidine injected into the medial septal area reduces the salivation induced by pilocarpine.
    Saad WA; de Arruda Camargo LA; Simões S; Saad WA; Guarda RS; Guarda IF
    Auton Neurosci; 2004 May; 112(1-2):31-6. PubMed ID: 15233928
    [TBL] [Abstract][Full Text] [Related]  

  • 54. I1 imidazoline receptors in cardiovascular regulation: the place of rilmenidine.
    Head GA; Burke SL
    Am J Hypertens; 2000 Jun; 13(6 Pt 2):89S-98S. PubMed ID: 10921527
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Is the hypotensive effect of clonidine and related drugs due to imidazoline binding sites?
    Guyenet PG
    Am J Physiol; 1997 Nov; 273(5):R1580-4. PubMed ID: 9374797
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interaction of the dopamine D2 receptor agonist quinpirole with sympathetic vasomotor tone and the central action of rilmenidine in conscious rabbits.
    van den Buuse M; Tritton SB; Burke SL; Head GA
    J Auton Nerv Syst; 1998 Oct; 72(2-3):187-94. PubMed ID: 9851568
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differential receptors involved in the cardiovascular effects of clonidine and rilmenidine in conscious rabbits.
    Head GA; Godwin SJ; Sannajust F
    J Hypertens Suppl; 1993 Dec; 11(5):S322-3. PubMed ID: 7908963
    [No Abstract]   [Full Text] [Related]  

  • 58. Brain structures involved in the hypotensive effects of rilmenidine: evaluation by [14C]2-deoxyglucose autoradiography.
    Macrae IM; Browne SE
    J Cardiovasc Pharmacol; 1995; 26 Suppl 2():S55-8. PubMed ID: 8642807
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Direct evidence for imidazoline (I1) receptor modulation of ethanol action on norepinephrine-containing neurons in the rostral ventrolateral medulla in conscious spontaneously hypertensive rats.
    Li G; Abdel-Rahman AA
    Alcohol Clin Exp Res; 2007 Apr; 31(4):684-93. PubMed ID: 17374048
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gene substitution/knockout to delineate the role of alpha 2-adrenoceptor subtypes in mediating central effects of catecholamines and imidazolines.
    Hein L; Limbird LE; Eglen RM; Kobilka BK
    Ann N Y Acad Sci; 1999 Jun; 881():265-71. PubMed ID: 10415924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.